tiprankstipranks
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market
Holding ATHA?
Track your performance easily

Athira Pharma (ATHA) Financial Statements

543 Followers

Athira Pharma Financial Overview

Athira Pharma's market cap is currently ―. The company's EPS TTM is $-2.849; its P/E ratio is -0.23; Athira Pharma is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -28.74M$ -26.86M$ -26.34M-$ -35.04M
EBITDA$ -28.44M$ -26.29M$ -26.30M-$ -34.80M
Net Income Common Stockholders$ -28.74M$ -26.86M$ -26.30M$ -27.55M$ -32.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 68.86M$ 91.77M$ 122.09M$ 147.42M$ 172.95M
Total Assets$ 86.25M$ 111.25M$ 133.46M$ 160.25M$ 184.70M
Total Debt$ 1.31M$ 1.41M$ 1.50M$ 1.58M$ 1.67M
Net Debt$ -67.54M$ -90.36M$ -120.59M$ -145.83M$ -171.28M
Total Liabilities$ 28.66M$ 27.92M$ 26.72M$ 30.06M$ 29.94M
Stockholders Equity$ 57.58M$ 83.33M$ 106.74M$ 130.19M$ 154.76M
Cash Flow-
Free Cash Flow$ -23.02M$ -22.36M$ -25.81M-$ -24.01M
Operating Cash Flow$ -23.02M$ -22.33M$ -25.80M$ -26.29M$ -23.98M
Investing Cash Flow$ 18.04M$ 26.56M$ 13.04M$ 6.39M$ 20.69M
Financing Cash Flow$ 12.00K$ 148.00K-$ 152.00K-
Currency in USD

Athira Pharma Earnings and Revenue History

Athira Pharma Debt to Assets

Athira Pharma Cash Flow

Athira Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis